JAK2 and hepatocellular carcinoma: Subsequent examinations of BSCA-activated hepatocellular carcinoma cells revealed alterations in the gene expression of JAK2 and STAT3, as well as changes in the levels of p-JAK2 and p-STAT3 proteins.